Occlusion Devices Market Report 2026

Occlusion Devices Market Overview

• Occlusion Devices market size has reached to $4.2 billion in 2025 • Expected to grow to $6.54 billion in 2030 at a compound annual growth rate (CAGR) of 9.2% • Growth Driver: Minimally Invasive Surgery Driving Growth In Uterine Fibroid Embolization Device Market • Market Trend: Next-Generation Device Enhances Targeted Embolization With Improved Efficiency And Extended Shelf Life • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Occlusion Devices Market?

Occlusion devices refer to medical instruments designed to block or restrict the flow of blood or other fluids within the body. They are commonly used in procedures such as embolization to treat conditions such as aneurysms, vascular malformations, or to control bleeding. These devices include products such coils, stents, and balloons and are crucial in minimally invasive surgeries. The main product types of occlusion devices are occlusion removal devices, embolization devices, tubal occlusion devices, and support devices. Occlusion removal devices are medical tools designed to clear blockages in blood vessels or other bodily pathways. These are used in various applications such as neurology, cardiology, peripheral vascular diseases, urology, oncology, and gynecology and end users involved are hospitals diagnostic centers and surgical centers, ambulatory care centers, research laboratories, and academic institutes.

What Is The Occlusion Devices Market Growth Forecast?

The occlusion devices market size is expected to see strong growth in the next few years. It will grow to $6.54 billion in 2030 at a compound annual growth rate (CAGR) of 9.2%. The growth in the forecast period can be attributed to growth in neurological disorders, rising minimally invasive surgeries, technological device innovation, expanding ambulatory care centers, favorable reimbursement policies. Major trends in the forecast period include shift toward minimally invasive procedures, rising use of catheter-based therapies, increasing preference for embolization procedures, growth in neurovascular interventions, demand for high-precision occlusion devices.

Global Occlusion Devices Market Segmentation

1) By Product: Occlusion Removal Devices, Embolization Devices, Tubal Occlusion Devices, Support Devices 2) By Application: Neurology, Cardiology, Peripheral Vascular Diseases, Urology, Oncology, Gynecology 3) By End User: Hospitals Diagnostic Centers And Surgical Centers, Ambulatory Care Centers, Research Laboratories And Academic Institutes Subsegments: 1) By Occlusion Removal Devices: Thrombectomy Devices, Catheter-Based Occlusion Removal Devices, Aspiration Systems, Mechanical Clot Retrieval Systems 2) By Embolization Devices: Coil Embolization Devices, Particle Embolization Devices, Balloon Embolization Devices, Gel Embolic Agents, Liquid Embolic Agents, Stent-Assisted Embolization Devices 3) By Tubal Occlusion Devices: Essure Devices, Hysteroscopic Sterilization Systems, Fallopian Tube Clips, Tubal Ligation Devices 4) By Support Devices: Occlusion Catheters, Guidewires For Occlusion, Supportive Sheaths, Stent-Grafts For Occlusion Support

What Is The Driver Of The Occlusion Devices Market?

The growing demand for minimally invasive techniques is expected to propel the growth of the occlusion devices market going forward. Minimally invasive surgeries refer to surgical approaches that use small incisions or natural body openings to access and treat internal structures, organs, or tissues to minimize trauma to the patient's body. Minimally invasive techniques provide medical, financial, and aesthetic benefits that appeal to patients and healthcare providers, driving the increasing demand across various medical disciplines. Occlusion devices are medical tools used in minimally invasive procedures to block or close off blood vessels, ducts, or other pathways in the body. These devices are often used in interventional cardiology, radiology, or other fields to treat conditions such as aneurysms, abnormal blood flow, or congenital heart defects. For instance, in June 2024, the International Society of Aesthetic Plastic Surgery (ISAPS) reported that in 2023, the total number of aesthetic procedures approached 35 million, with combined surgical and non-surgical procedures rising 3.4% to reach 34.9 million. Therefore, the growing demand for minimally invasive techniques drives the growth of the occlusion devices industry.

Key Players In The Global Occlusion Devices Market

Major companies operating in the occlusion devices market are Johnson & Johnson, Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, B. Braun Melsungen AG, Terumo Corporation, Cook Group Incorporated, Merit Medical Systems Inc., Lepu Medical Technology Beijing Co. Ltd., MicroPort Scientific Corporation, Penumbra Inc., Asahi Intecc Co. Ltd., Angiodynamics Inc., LeMaitre Vascular Inc., Elixir Medical Corporation, Vascular Concepts Ltd., Occlutech, W L Gore & Associates Inc., LifeTech Scientific Corporation, Cardiovascular Systems Inc., Venus Medtech, CeloNova Biosciences, Cordis Corporation, Pfizer Inc., Sirtex Medical Limited, Nordion Canada Inc., AtriCure Inc., Phenox GmbH, Balt Extrusion SAS

Global Occlusion Devices Market Trends and Insights

Major companies in the occlusion devices market are prioritizing the development of innovative solutions, including next-generation devices, to enhance targeted embolization procedures. A next-generation device represents an advanced iteration of existing technology, offering superior performance, enhanced features, and innovative capabilities. For example, in July 2025, Embolx, a US-based medical equipment manufacturer, introduced the Sniper G3 Balloon Occlusion Microcatheter, which significantly improves targeted embolization with greater efficiency, ease of use, and extended shelf life. This third-generation device doubles shelf life to 24 months, providing better inventory flexibility. Developed with direct feedback from interventional radiologists, it features improved trackability and a simplified preparation process that reduces setup time to under a minute. These enhancements demonstrate Embolx’s focus on physician-centered design, aimed at streamlining clinical workflows and optimizing procedural outcomes. The Sniper G3 is available in all standard lengths and is ready for global distribution, reinforcing its position as a leading tool in embolization therapy.

What Are Latest Mergers And Acquisitions In The Occlusion Devices Market?

In November 2023, Amring Pharmaceuticals Inc., a US-based specialty pharmaceutical company, acquired Laminar Inc. for an undisclosed amount. This acquisition brings together Nordic Pharma's pharmaceutical expertise with Visant’s FDA-cleared hyaluronic acid derivative, LACRIFILL, a canalicular occlusive device designed to temporarily block tear drainage by occluding the canalicular system. Visant Medical Inc. is a US-based manufacturer of medical devices intended to provide treatment for dry eye.

Regional Outlook

North America was the largest region in the occlusion devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Occlusion Devices Market?

The occlusion devices market consists of sales of liquid embolic agents, flow diverters, balloon occlusion devices, emblemization coils, and endovascular stents. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.